Results
SMS Pharma Q2 PAT Up 57% YoY, Raises FY27 Guidance
SMS Pharmaceuticals reported Q2FY27 revenue growth of 30% YoY to ₹316.08 crore, driven by strong volumes and improved pricing.
PAT surged 57% YoY to ₹39.57 crore with EBITDA margin expanding 145 bps t
